BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37283624)

  • 1. Establishment and validation of a clinical nomogram model based on serum YKL-40 to predict major adverse cardiovascular events during hospitalization in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Li J; Wang W; Wang Y; Chen Z; Zhang J
    Front Med (Lausanne); 2023; 10():1158005. PubMed ID: 37283624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP; Guo QC; Mu N; Liu CH
    Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L; Wang Y; Wang W; Wang Z
    Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
    Wu ZF; Su WT; Chen S; Xu BD; Zong GJ; Fang CM; Huang Z; Hu XJ; Wu GY; Ma XL
    Ther Clin Risk Manag; 2023; 19():699-712. PubMed ID: 37641783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Serum YKL-40 and TNF-
    Fang C; Chen Z; Zhang J; Pan J; Jin X; Yang M; Huang L
    Cardiol Res Pract; 2022; 2022():4905954. PubMed ID: 36051575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H; Zhu Y; Shen G; Wang Z; Li W
    Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Int J Clin Pract; 2022; 2022():3659381. PubMed ID: 36225534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of carotid intima-media thickness and plasma homocysteine in acute ST-segment elevation myocardial infarction.
    Ou Q; Zhang J; Wen X; Yang L; Tao L
    Cardiovasc Diagn Ther; 2023 Dec; 13(6):917-928. PubMed ID: 38162099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Wang L; Yang L; Li T; Geng S
    J Inflamm Res; 2023; 16():3185-3196. PubMed ID: 37529768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.
    Zhu H; Li Z; Xu X; Fang X; Chen T; Huang J
    PeerJ; 2020; 8():e9068. PubMed ID: 32355581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum YKL-40 level predicts myocardial reperfusion and in-hospital MACE in patients with STEMI.
    Cetin M; Kocaman SA; Canga A; Kırbaş A; Yılmaz A; Erdoğan T; Akgül O; Uğurlu Y; Durakoğlugil ME
    Herz; 2013 Mar; 38(2):202-9. PubMed ID: 22955689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N; Qi X; Dang Y; Li Y; Wang G; Liu X; Zhu N; Fu J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):513. PubMed ID: 33297955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.
    Yang L; Cong H; Lu Y; Chen X; Liu Y
    Ann Transl Med; 2021 Jan; 9(2):126. PubMed ID: 33569428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction.
    Bai Z; Hu S; Wang Y; Deng W; Gu N; Zhao R; Zhang W; Ma Y; Wang Z; Liu Z; Shen C; Shi B
    Ann Transl Med; 2021 Jul; 9(14):1162. PubMed ID: 34430603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y; Peng Z
    Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Eur Radiol; 2021 Feb; 31(2):1140-1150. PubMed ID: 32856164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.